Skip to content
★ Sign in to follow
RR

R Redfern

GlaxoSmithKline plc
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€35k

Latest filing published 31 Jul 2018 for GlaxoSmithKline plc, €35k.

Filing timeline

BuySale
R Redfern

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

R Redfern: trading record in brief

Only one filing by R Redfern is known so far (31 July 2018): an open-market sale, €35k, in GlaxoSmithKline plc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to R Redfern

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▼
    PCA of Mr D Redfern (Chief Strategy Officer)ExecutivesGlaxoSmithKline plc
    31,579 GBP27FCA-NSM
    2,005 shares@ £15.75100.0% of flowLondon Stock Exchange ( XLON)ISIN GB0009252882FCA-NSM:LSE20180731163735_13738403_20200330111419815_165-1

1 of 1 declaration